TSHA EBITDA Margin
Taysha Gene Therapies Inc · EBITDA Margin
TSHA EBITDA Margin
Latest reported-2714.33%period ending
TSHA TTM EBITDA Margin (-6482.65% → -2714.33%)
TTM ebitda margin
High-resolution chart · PNG
TSHA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -2,714.33% | |
| -1,728.3764% | |
| -1,107.623% | |
| -1,564.2789% | |
| -1,129.6616% | |
| -1,183.1534% | |
| -1,055.4542% | |
| -208.4922% | |
| -860.3356% | |
| -798.1563% | |
| -680.8427% | |
| -1,453.6205% | |
| -1,233.6457% | |
| -1,785.9046% | |
| -6,482.6539% |